|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-07-31 Tax Withholding |
2008-08-01 4:53 pm | CELL GENESYS INC | CEGE | DOW ROBERT J (SVP & Chief Medical Officer) | 10,380 | $3.105 | $32,230 | 14,620 (Direct) | View |
| 2007-07-30 Option Award |
2007-08-01 4:14 pm | CELL GENESYS INC | CEGE | DOW ROBERT J (SVP & Chief Medical Officer) | 25,000 | $0 | $0 | 25,000 (Direct) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2008-02-06 Option Award | 2008-02-08 4:11 pm |
2008-02-06 2018-02-06 | CELL GENESYS INC | CEGE | DOW ROBERT J (SVP & Chief Medical Officer) | 65,000 | $1.84 | 65,000 (Direct) | View |
| 2007-02-07 Option Award | 2007-02-09 5:24 pm | 2007-02-07 2017-02-07 | CELL GENESYS INC | CEGE | DOW ROBERT J (SVP & Chief Medical Officer) | 50,000 | $3.07 | 50,000 (Direct) |
View |
| 2006-02-07 Option Award |
2006-02-09 9:54 pm | 2007-02-07 2016-02-07 |
CELL GENESYS INC | CEGE | DOW ROBERT J (SVP Medical Affairs) | 30,000 | $6.07 | 30,000 (Direct) | View |
| 2005-04-29 Option Award | 2005-04-29 7:53 pm |
2006-03-01 2015-04-29 | CELL GENESYS INC | CEGE | DOW ROBERT J (Sr. V.P. Medical Affairs) | 150,000 | $4.66 | 150,000 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Tue, 02 Dec 2008 00:11:03 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |